EVP R&D, Chief Medical Officer
Wed, Feb 12, 2025
Feb 12
171,813 shares @ $32.69
Decreased holdings by -65.40%
Largest trade (out of 157)
Planned (10b5-1)Large Trade
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 23% above 200-day moving average